Prolyl hydroxylase 2: A novel regulator of β 2-adrenoceptor internalization

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 12, 2011, Pages 2712-2722

  Yan, Biao ^a,b   Huo, Zhaoxia ^a,b   Liu, Ying ^a,b,c   Lin, Xiaoping ^a   Li, Jun ^a   Peng, Luying ^a   Zhao, Hong ^a   Zhou, Zhao Nian ^d   Liang, Xingqun ^e   Liu, Yi ^a   Zhu, Weidong ^a   Liang, Dandan ^a   Li, Li ^a   Sun, Yunfu ^a   Cui, Jianmin ^f   Chen, Yi Han ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

^c Heilongjiang Province Blood Center   (China)

^d Chinese Academy of Sciences   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

arrestin 2; 2 adrenoceptor; Hydroxylation; Internalization; Prolyl hydroxylase

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ARRESTIN; EGLN1 PROTEIN, HUMAN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; RETINA S ANTIGEN; SMALL INTERFERING RNA;

ARTICLE; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; CYTOSOL; DRUG ANTAGONISM; ENDOCYTOSIS; GENETICS; HUMAN; IMMUNOPRECIPITATION; KIDNEY; MASS SPECTROMETRY; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ARRESTINS; CELL MEMBRANE; CELLS, CULTURED; CYTOSOL; ENDOCYTOSIS; HUMANS; IMMUNOPRECIPITATION; KIDNEY; PHOSPHORYLATION; PROCOLLAGEN-PROLINE DIOXYGENASE; RECEPTORS, ADRENERGIC, BETA-2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 82455220291     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01268.x     Document Type: Article

References (36)

1. 2-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol. 2006; 117: 18-24.
2. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature. 2002; 415: 206-12.
3. Sibley DR, Strasser RH, Benovic JL, et al. Phosphorylation/ dephosphorylation of the β-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution. Proc Natl Acad Sci USA. 1986; 83: 9408-12.
4. Chuang DM, Costa E. Evidence for internalization of the recognition site of β-adrenergic receptors during receptor subsensitivity induced by (-)-isoproterenol. Proc Natl Acad Sci USA. 1979; 76: 3024-8.
5. Kaelin Jr WG, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008; 30: 393-402.
6. Takeda K, Ho VC, Takeda H, et al. Placental but not heart defects are associated with elevated hypoxia-inducible factor α levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol. 2006; 26: 8336-46.
7. Minamishima YA, Moslehi J, Bardeesy N, et al. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood. 2008; 111: 3236-44.
8. Percy MJ, Zhao Q, Flores A, et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci USA. 2006; 103: 654-9.
9. Jong de W, Lukovic L, Jones CR, et al. Receptor density in the rat heart following ischaemia and prolonged reperfusion. Clin Exp Pharmacol Physiol Suppl. 1995; 22: S279-80.
10. Leon-Velarde F, Bourin MC, Germack R, et al. Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion.Am J Physiol Regul Integr Comp Physiol. 2001; 280: R274-81.
11. 2-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci Signal. 2009; 2: ra33.
12. Wang G, Moniri NH, Ozawa K, et al. Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc Natl Acad Sci USA. 2006; 103: 1295-300.
13. Elbashir SM, Martinez J, Patkaniowska A, et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 2001; 20: 6877-88.
14. Appelhoff RJ, Tian YM, Raval RR, et al. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem. 2004; 279: 38458-65.
15. Barth S, Edlich F, Berchner-Pfannschmidt U, et al. Hypoxia-inducible factor prolyl-4-hydroxylase PHD2 protein abundance depends on integral membrane anchoring of FKBP38. J Biol Chem. 2009; 284: 23046-58.
16. Metzen E, Berchner-Pfannschmidt U, Stengel P, et al. Intracellular localisation of human HIF-1 α hydroxylases: implications for oxygen sensing. J Cell Sci. 2003; 116: 1319-26.
17. Premont RT, Gainetdinov RR. Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol. 2007; 69: 511-34.
18. 2 adrenergic receptor. J Biol Chem. 2006; 281: 1261-73.
19. DeWire SM, Ahn S, Lefkowitz RJ, et al. β-arrestins and cell signaling. Annu Rev Physiol. 2007; 69: 483-510.
20. Hirota K, Semenza GL. Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Biochem Biophys Res Commun. 2005; 338: 610-6.
21. Fong GH, Takeda K. Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 2008; 15: 635-41.
22. Willam C, Nicholls LG, Ratcliffe PJ, et al. The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor α. Adv Enzyme Regul. 2004; 44: 75-92.
23. 2-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm. EMBO Rep. 2001; 2: 615-20.
24. Cummins EP, Berra E, Comerford KM, et al. Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity. Proc Natl Acad Sci USA. 2006; 103: 18154-9.
25. Mikhaylova O, Ignacak ML, Barankiewicz TJ, et al. The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress. Mol Cell Biol. 2008; 28: 2701-17.
26. Haffey WD, Mikhaylova O, Meller J, et al. iTRAQ Proteomic identification of pVHL-dependent and -independent targets of Egln1 prolyl hydroxylase knockdown in renal carcinoma cells. Adv Enzyme Regul. 2009; 49: 121-32.
27. 2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/β-arrestin complex. J Cell Bio. 2002; 158: 563-75.
28. Perrino C, Schroder JN, Lima B, et al. Dynamic regulation of phosphoinositide 3-kinase-γ activity and β-adrenergic receptor trafficking in end-stage human heart failure. Circulation. 2007; 116: 2571-9.
29. Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol. 2003; 21: 255-61.
30. Myllyharju J, Kivirikko KI. Characterization of the iron- and 2-oxoglutarate-binding sites of human prolyl 4-hydroxylase. EMBO J. 1997; 16: 1173-80.
31. Przysiecki CT, Staggers JE, Ramjit HG, et al. Occurrence of β-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domains. Proc Natl Acad Sci USA. 1987; 84: 7856-60.
32. Lahousse SA, Carter JJ, Xu XJ, et al. Differential growth factor regulation of aspartyl-(asparaginyl)- β-hydroxylase family genes in SH-Sy5y human neuroblastoma cells. BMC Cell Biol. 2006; 7: 41.
33. 2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load. Circ Res. 2008; 102: 1389-97.
34. Moore CAC, Milano SK, Benovic JL. Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol. 2007; 69: 451-82.
35. Ren XR, Reiter E, Ahn S, et al. Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci USA. 2005; 102: 1448-53.
36. Cheng ZJ, Zhao J, Sun Y, et al. β-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between β-arrestin and CXCR4. J Biol Chem. 2000; 275: 2479-85.